News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
544,056 Results
Type
Article (16547)
Company Profile (144)
Press Release (527362)
Multimedia
Podcasts (24)
Webinars (10)
Section
Business (177559)
Career Advice (528)
Deals (27167)
Drug Delivery (42)
Drug Development (61364)
Employer Resources (53)
FDA (11232)
Job Trends (9923)
News (260206)
Policy (21376)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1178)
Accelerated approval (35)
ADA (50)
Adcomms (6)
Allergies (133)
Alliances (35297)
ALS (126)
Alzheimer's disease (1151)
Antibody-drug conjugate (ADC) (372)
Approvals (11861)
Artificial intelligence (396)
ASCO (328)
Autoimmune disease (254)
Automation (33)
Bankruptcy (276)
Belgium (2)
Best Places to Work (8161)
BIO (48)
Biologics (10)
BIOSECURE Act (10)
Biosimilars (126)
BioSpace Insights (31)
Biotechnology (90)
Bispecific (1)
Bladder cancer (167)
Brain cancer (41)
Breast cancer (610)
Cancer (4717)
Cardiovascular disease (332)
Career advice (456)
Career pathing (4)
CAR-T (241)
CDC (29)
CDMO (22)
Celiac Disease (2)
Cell therapy (638)
Cervical cancer (45)
Clinical research (55247)
Collaboration (1401)
Commercialization (3)
Compensation (1544)
Complete response letters (39)
COVID-19 (1193)
CRISPR (80)
C-suite (875)
Cystic fibrosis (106)
Data (7104)
Decentralized trials (2)
Denatured (4)
Depression (118)
Dermatology (83)
Diabetes (488)
Diagnostics (4966)
Digital health (43)
Diversity (2)
Diversity, equity & inclusion (19)
Drug discovery (182)
Drug pricing (89)
Drug shortages (8)
Duchenne muscular dystrophy (183)
Earnings (76358)
Editorial (27)
Employer branding (6)
Employer resources (49)
Events (98967)
Executive appointments (778)
FDA (14303)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (18)
Frontotemporal dementia (25)
Funding (1086)
Gene editing (159)
Generative AI (16)
Gene therapy (423)
GLP-1 (497)
Government (1956)
Grass and pollen (3)
Guidances (321)
Healthcare (12515)
Hematology (127)
HIV (58)
Huntington's disease (27)
IgA nephropathy (91)
Immunology and inflammation (130)
Immuno-oncology (80)
Indications (181)
Infectious disease (1420)
Inflammatory bowel disease (143)
Inflation Reduction Act (10)
Influenza (94)
Intellectual property (274)
Interviews (60)
IPO (13157)
IRA (20)
Job creations (2155)
Job search strategy (430)
JPM (5)
Kidney cancer (22)
Labor market (6)
Layoffs (96)
Leadership (5)
Legal (5822)
Licensing (19)
Liver cancer (62)
Longevity (24)
Lung cancer (681)
Lymphoma (351)
Machine learning (33)
Management (18)
Manufacturing (666)
Marketing (9)
MASH (143)
Medical affairs (2)
Medical device (9663)
Medtech (9838)
Mergers & acquisitions (15110)
Metabolic disorders (1012)
mRNA (89)
Multiple sclerosis (124)
NASH (4)
Neurodegenerative disease (248)
Neuropsychiatric disorders (50)
Neuroscience (2160)
NextGen: Class of 2026 (4028)
Non-profit (2432)
Obesity (368)
Opinion (76)
Ovarian cancer (184)
Pain (223)
Pancreatic cancer (288)
Parkinson's disease (230)
Partnered (17)
Patents (520)
Patient recruitment (567)
Patient selection (2)
Peanut (52)
People (45590)
Peptides (2)
Pharmaceutical (33)
Pharmacy benefit managers (21)
Phase 1 (17273)
Phase 2 (24298)
Phase 3 (17490)
Pipeline (8626)
Policy (143)
Postmarket research (2114)
Preclinical (7569)
Press Release (36)
Prostate cancer (253)
Psychedelics (12)
Radiopharmaceuticals (226)
Rare diseases (731)
Real estate (3393)
Recruiting (16)
Regenerative medicine (2)
Regulatory (17475)
Reports (28)
Research institute (1031)
Resumes & cover letters (60)
Rett syndrome (42)
RNA editing (8)
RSV (54)
Schizophrenia (111)
Series A (181)
Series B (130)
Service/supplier (5)
Sickle cell disease (93)
Special edition (7)
Spinal muscular atrophy (99)
Sponsored (8)
Startups (2184)
Stomach cancer (5)
Supply chain (62)
Tariffs (25)
The Weekly (20)
Vaccines (513)
Venture capital (32)
Weight loss (179)
Women's health (101)
Worklife (3)
Date
Last 7 days (315)
Last 30 days (1461)
Last 365 days (21460)
2026 (15381)
2025 (21637)
2024 (25637)
2023 (29511)
2022 (37885)
2021 (40863)
2020 (37974)
2019 (29106)
2018 (21834)
2017 (21235)
2016 (20784)
2015 (27221)
2014 (23775)
2013 (19927)
2012 (21990)
2011 (22452)
2010 (22300)
Location
Africa (321)
Alabama (84)
Alaska (4)
Arizona (337)
Arkansas (12)
Asia (21807)
Australia (2877)
California (13051)
Canada (3370)
China (809)
Colorado (524)
Connecticut (474)
Delaware (284)
Europe (35071)
Florida (1951)
Georgia (428)
Hawaii (3)
Idaho (48)
Illinois (883)
India (61)
Indiana (424)
Iowa (19)
Japan (451)
Kansas (116)
Kentucky (34)
Louisiana (53)
Maine (29)
Maryland (1371)
Massachusetts (8710)
Michigan (331)
Minnesota (619)
Mississippi (4)
Missouri (104)
Montana (20)
Nebraska (13)
Nevada (129)
New Hampshire (64)
New Jersey (3086)
New Mexico (17)
New York (3119)
North Carolina (1450)
North Dakota (7)
Northern California (6620)
Ohio (317)
Oklahoma (17)
Oregon (19)
Pennsylvania (2430)
Puerto Rico (24)
Rhode Island (35)
South America (567)
South Carolina (80)
South Dakota (1)
Southern California (5388)
Tennessee (148)
Texas (2106)
United States (43304)
Utah (386)
Vermont (2)
Virginia (242)
Washington D.C. (48)
Washington State (1022)
West Virginia (1)
Wisconsin (95)
Wyoming (1)
544,056 Results for "american regent inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of Sterility
September 3, 2026
·
4 min read
Press Releases
Endogenex Announces Publication of REGENT-1 Clinical Study Results in Diabetes, Obesity and Metabolism
March 17, 2026
·
4 min read
Pharm Country
American Regent introduces FDA-approved Epinephrine Injection, USP
American Regent announces the launch of sulfite-free Epinephrine Injection, USP.
March 30, 2023
·
7 min read
Policy
American Regent Introduces Potassium Phosphates, USP; FDA-Approved and “AP” Rated¹
American Regent announces the launch and availability of Potassium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to Potassium Phosphates.1 Potassium Phosphates Injection, USP is indicated as a source of phosphorus:
October 19, 2023
·
9 min read
Pharm Country
American Regent Introduces Levocarnitine Injection, USP; FDA-Approved, AP Rated, and Therapeutically Equivalent to Carnitor®¹
American Regent announces the release and availability of Levocarnitine Injection, USP, FDA-approved, “AP” rated, and therapeutically equivalent to Carnitor®.
October 10, 2023
·
6 min read
Press Releases
American Regent introduces FDA-approved Epinephrine Injection, USP in 30 mL
October 29, 2024
·
8 min read
Drug Development
American Regent Announces Results From Phase 3 HEART-FID Trial with INJECTAFER®
American Regent, Inc., a Daiichi Sankyo Group company, announced results from the phase 3 HEART-FID trial of INJECTAFER® for the treatment of iron deficiency in adult heart failure patients with reduced ejection fraction.
August 26, 2023
·
12 min read
China
New biotech group rises to fuel American rockets in China ‘space race’
Members of the American Biotech Innovation Alliance (ABIA) want to build a national biotech strategy—just like China did years ago.
June 10, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Genoskin Doubles US Foothold to Launch Local Primary HumanMast Cell Production for North American Customers
New 8,000-square-foot Laboratory and Office Facility in Salem, Massachusetts, will Provide Local Primary Human Mast Cell Production Capabilities to Address Increasing US Demand and Offer Faster Access to North American Researchers
July 2, 2026
·
1 min read
Press Releases
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
July 2, 2026
·
6 min read
1 of 54,406
Next
